Techno Medica (6678) · InitiativeFirst statedLatest Treasury Shares (2026-08-06): "Other"
Review of Product Lineup Following the Discontinuation of Production of Certain Models of Blood Collection Tube Preparation Equipment
First written in FY2026. 1 of 5 entries say "Advanced", first in 2026-05-26. Latest entry: 2026-08-06.
5entries
1years
4from disclosures
How it moved
Same theme, other companies
Product discontinuations and inventory losses following a product portfolio reviewA theme 2 companies write about · 2 as a headwind · 0 as a tailwind
0 other companies' latest entry also says "Other".
Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Full recordFilings, disclosures and news, newest first
- 2026-08-06OtherTreasury Shares
「Reason for acquiring treasury shares: We acquired treasury shares to enhance shareholder returns and improve capital efficiency.」
No connection with the thread concerning the discontinuation of production of certain models could be confirmed. - FY2026First statedAnnual report
「Net income was ¥1,070.987 million, up 6.6% from the previous fiscal year, following the decision to end production of certain models of blood collection tube preparation equipment from a sales strategy perspective and the recognition of related costs as extraordinary losses.」
The company ended production of certain models of blood collection tube preparation equipment as a sales strategy decision and recognised related costs, including a ¥192.5 million provision for losses on the end of production, as extraordinary losses. The end of production for existing products and the review of the product mix were disclosed for the first time.